206 related articles for article (PubMed ID: 31325048)
1. Trends in Unilateral and Contralateral Prophylactic Mastectomy Use in Ductal Carcinoma In Situ of the Breast: Patterns and Predictors.
Zhang B; Coopey SB; Gadd MA; Hughes KS; Chang DC; Oseni TO
Ann Surg Oncol; 2019 Nov; 26(12):3863-3873. PubMed ID: 31325048
[TBL] [Abstract][Full Text] [Related]
2. Factors associated with the increasing trend of contralateral prophylactic mastectomy among patients with ductal carcinoma in situ: Analysis of Surveillance, Epidemiology, and End Results data.
You Q; Chen K; Li Y; Lai J; Fang Y; Shen S; Liu Y; Su F; Yu F
Breast; 2018 Aug; 40():147-155. PubMed ID: 29804045
[TBL] [Abstract][Full Text] [Related]
3. Impact of breast reconstruction on the decision to undergo contralateral prophylactic mastectomy.
Ashfaq A; McGhan LJ; Pockaj BA; Gray RJ; Bagaria SP; McLaughlin SA; Casey WJ; Rebecca AM; Kreymerman P; Wasif N
Ann Surg Oncol; 2014 Sep; 21(9):2934-40. PubMed ID: 24756811
[TBL] [Abstract][Full Text] [Related]
4. Predictors that influence contralateral prophylactic mastectomy election among women with ductal carcinoma in situ who were evaluated for BRCA genetic testing.
Elsayegh N; Kuerer HM; Lin H; Gutierrez Barrera AM; Jackson M; Muse KI; Litton JK; Albarracin C; Afrough A; Hortobagyi GN; Arun BK
Ann Surg Oncol; 2014 Oct; 21(11):3466-72. PubMed ID: 24796968
[TBL] [Abstract][Full Text] [Related]
5. Trends in Treatment Patterns and Clinical Outcomes in Young Women Diagnosed With Ductal Carcinoma In Situ.
Park HL; Chang J; Lal G; Lal K; Ziogas A; Anton-Culver H
Clin Breast Cancer; 2018 Apr; 18(2):e179-e185. PubMed ID: 28941977
[TBL] [Abstract][Full Text] [Related]
6. Use of immediate breast reconstruction and choice for contralateral prophylactic mastectomy.
Hoskin TL; Hieken TJ; Degnim AC; Jakub JW; Jacobson SR; Boughey JC
Surgery; 2016 Apr; 159(4):1199-209. PubMed ID: 26704783
[TBL] [Abstract][Full Text] [Related]
7. Contralateral Prophylactic Mastectomy Decisions in a Population-Based Sample of Patients With Early-Stage Breast Cancer.
Jagsi R; Hawley ST; Griffith KA; Janz NK; Kurian AW; Ward KC; Hamilton AS; Morrow M; Katz SJ
JAMA Surg; 2017 Mar; 152(3):274-282. PubMed ID: 28002555
[TBL] [Abstract][Full Text] [Related]
8. Increasing rates of contralateral prophylactic mastectomy among patients with ductal carcinoma in situ.
Tuttle TM; Jarosek S; Habermann EB; Arrington A; Abraham A; Morris TJ; Virnig BA
J Clin Oncol; 2009 Mar; 27(9):1362-7. PubMed ID: 19224844
[TBL] [Abstract][Full Text] [Related]
9. Patient and surgeon characteristics associated with increased use of contralateral prophylactic mastectomy in patients with breast cancer.
Arrington AK; Jarosek SL; Virnig BA; Habermann EB; Tuttle TM
Ann Surg Oncol; 2009 Oct; 16(10):2697-704. PubMed ID: 19653045
[TBL] [Abstract][Full Text] [Related]
10. Contralateral prophylactic mastectomy in an Asian population: a single institution review.
Sim Y; Tan VK; Ho GH; Wong CY; Madhukumar P; Tan BK; Yong WS; Ng YY; Ong KW
Breast; 2014 Feb; 23(1):56-62. PubMed ID: 24275318
[TBL] [Abstract][Full Text] [Related]
11. Patterns and correlates of local therapy for women with ductal carcinoma-in-situ.
Katz SJ; Lantz PM; Janz NK; Fagerlin A; Schwartz K; Liu L; Deapen D; Salem B; Lakhani I; Morrow M
J Clin Oncol; 2005 May; 23(13):3001-7. PubMed ID: 15860856
[TBL] [Abstract][Full Text] [Related]
12. Trends in contralateral prophylactic mastectomy for unilateral cancer: a report from the National Cancer Data Base, 1998-2007.
Yao K; Stewart AK; Winchester DJ; Winchester DP
Ann Surg Oncol; 2010 Oct; 17(10):2554-62. PubMed ID: 20461470
[TBL] [Abstract][Full Text] [Related]
13. Perceptions of contralateral breast cancer: an overestimation of risk.
Abbott A; Rueth N; Pappas-Varco S; Kuntz K; Kerr E; Tuttle T
Ann Surg Oncol; 2011 Oct; 18(11):3129-36. PubMed ID: 21947590
[TBL] [Abstract][Full Text] [Related]
14. Association of Regional Intensity of Ductal Carcinoma In Situ Treatment With Likelihood of Breast Preservation.
Punglia RS; Cronin AM; Uno H; Stout NK; Ozanne EM; Greenberg CC; Frank ES; Schrag D
JAMA Oncol; 2017 Jan; 3(1):101-104. PubMed ID: 27442038
[TBL] [Abstract][Full Text] [Related]
15. Variations in treatment for ductal carcinoma in situ in elderly women.
Gold HT; Dick AW
Med Care; 2004 Mar; 42(3):267-75. PubMed ID: 15076826
[TBL] [Abstract][Full Text] [Related]
16. The influence of age on the breast surgery decision-making process.
Bleicher RJ; Abrahamse P; Hawley ST; Katz SJ; Morrow M
Ann Surg Oncol; 2008 Mar; 15(3):854-62. PubMed ID: 18058182
[TBL] [Abstract][Full Text] [Related]
17. Growing Use of Mastectomy for Ductal Carcinoma-In Situ of the Breast Among Young Women in the United States.
Rutter CE; Park HS; Killelea BK; Evans SB
Ann Surg Oncol; 2015 Jul; 22(7):2378-86. PubMed ID: 25564175
[TBL] [Abstract][Full Text] [Related]
18. Sentinel lymph node biopsy in contralateral prophylactic mastectomy: are we overtreating? Experience at a tertiary care hospital.
Kuwajerwala NK; Dekhne NS; Pentiak PA; Fend D; Callahan RE; Amine M; Lucia V; Swartz J
Clin Breast Cancer; 2013 Aug; 13(4):287-91. PubMed ID: 23706482
[TBL] [Abstract][Full Text] [Related]
19. Assessing the Effect of Lifetime Contralateral Breast Cancer Risk on the Selection of Contralateral Prophylactic Mastectomy for Unilateral Breast Cancer.
Hegde JV; Wang X; Attai DJ; DiNome ML; Kusske A; Hoyt AC; Hurvitz SA; Weidhaas JB; Steinberg ML; McCloskey SA
Clin Breast Cancer; 2018 Apr; 18(2):e205-e218. PubMed ID: 29050918
[TBL] [Abstract][Full Text] [Related]
20. Incidence of and treatment for ductal carcinoma in situ of the breast.
Ernster VL; Barclay J; Kerlikowske K; Grady D; Henderson C
JAMA; 1996 Mar; 275(12):913-8. PubMed ID: 8598618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
